Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway

• Main Authors: Fujing Wang (Author), Jia'er Fan (Author), Tingting Pei (Author), Zhuo'en He (Author), Jiaxing Zhang (Author), Liliang Ju (Author), Zhongxiao Han (Author), Mingqing Wang (Author), Wei Xiao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, so there is an urgent need to suppress its development at early stage. Shenkang pills (SKP) are a hospital prescription selected and optimized from effective traditional Chinese medicinal formulas for clinical treatment of DN...